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Intra-articularAbstract Background: Knee arthroscopy is one of the day case procedures which may be diagnos-
tic or therapeutic. Postoperative analgesia is important for early ambulation and short hospital
stay. This prospective randomized study was designed to compare the analgesic effect of intra-
articular dexmedetomidine versus ketamine as adjuvant to bupivacaine following knee arthroscopy.
Method: 75 patients ASA physical status I and II undergoing knee arthroscopy under general anes-
thesia were included in this study. Patients were divided into three groups according to intra-
articular injected combination at the end of the arthroscopy. Group B/D received 25 ml 0.25%
bupivacaine and dexmedetomidine 1 lg/kg, group B/K received 25 ml 0.25% bupivacaine and keta-
mine 1 mg/kg, and control group B received 25 ml 0.25% bupivacaine only. Postoperative pain
using visual analogue score (VAS), the time to the ﬁrst postoperative analgesic request, the total
dose of postoperative analgesia during the ﬁrst 24 h, and possible side effects were recorded.
Results: Visual analogue score (VAS) was signiﬁcantly less in B/D group in comparison with B/K
group after the 1st hour and thereafter. Also VAS was higher in B group compared to the other two
groups (P< 0.05). Time to ﬁrst postoperative analgesic request was longer in the B/D group
(479.2 ± 34.9 min) than in B/K group (356.7 ± 39.2 min), but in both groups it was longer than
in B group (312.4 ± 18.8 min), (P< 0.05).
The total dose of postoperative analgesia (paracetamol consumption) during the ﬁrst 24 h was sig-
niﬁcantly low in B/D group (758.0 ± 153.0 mg) compared to both B/K and B groups
(1041.2 ± 178.6 mg and 1368.0 ± 227.2 mg) respectively (P< 0.05).
Conclusion: Intra-articular bupivacaine/dexmedetomidine provides better analgesia compared to
bupivacaine/ketamine and both are superior to bupivacaine alone following knee arthroscopy.
ª 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
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Knee arthroscopy is a minimally invasive day case procedure
which may be done for diagnosis, meniscectomy or debride-
ment. Arthroscopic surgery is associated with a variable degree
of postoperative pain, which is caused by an irritation of free
nerve endings of the synovial tissue, anterior fat pad, and joint
capsule due to surgical excision and resection [1].
Postoperative pain control is very important for early rehabil-
itation and short hospital stay. Several postoperative analgesic
modalities were tried such as systemic drugs, central or periph-
eral nerve blocks and intra-articular injections aiming at reach-
ing the ideal technique for postoperative pain control [2].
Many studies were done using different intra-articular agents
as local anesthetics, opioids, ketamine, NSAIDS and a2-
adrenergic agonists for prevention and treatment of pain after
knee surgeries [3]. Dexmedetomidine is a potent and highly
selective a2-adrenoreceptor agonist. It has sedative-hypnotic,
anxiolytic, analgesic, anesthetic and sympatholytic effects [4].
Intra-articular dexmedetomidine was used in several studies
to enhance postoperative analgesia after knee arthroscopy
with an increased time to ﬁrst analgesic request and a
decreased need for postoperative analgesia [2]. Ketamine has
been introduced into clinical practice for nearly 46 years, with
the objective to act as an anesthetic substance with analgesia,
amnesia, unconsciousness, and immobility properties.
Ketamine has been found to interact with a number of recep-
tors such as opioids, muscarinic and N-methyl-D-aspartate
receptors (NMDAr) [5].
Although central NMDAr, especially when located in the
spinal cord have received a great deal of attention, recent evi-
dence suggests that NMDAr located in peripheral somatic and
visceral pain pathways play an important role in nociception
[6]. NMDAr have been found to exist in joints, as demon-
strated in the rat model by Yu et al. [7].
The intra-articular application of ketamine after arthro-
scopic knee surgery leads to a signiﬁcant decrease of postoper-
ative analgesic demand and decreases patients’ subjective level
of pain compared to intra-articular application of bupivacaine
or placebo [8]. However, there is no study comparing the effect
of intra-articular dexmedetomidine versus ketamine. The
aim of this prospective randomized study was to evaluate the
effect of adding dexmedetomidine versus ketamine as adjuvant
to intra-articular bupivacaine for postoperative analgesia after
knee arthroscopy.2. Patients and methods
2.1. Study design
This is a randomized parallel-group controlled study with
allocation ratio (1:1:1) was done in orthopedic theater in
Kasr Alaini hospital in the period between October 2013 and
August 2014 after approval of ethics committee and
obtaining written informed consent from all patients.
Patients recruited in this study were scheduled to knee arthro-
scopy under general anesthesia to evaluate the postoperative
analgesic effect of intra-articular dexmedetomidine versus
ketamine as adjuvant to bupivacaine in comparison with bupi-
vacaine alone.2.2. Patient
75 patients aged 20–50 years of both sexes, ASA physical sta-
tus I–II were enrolled in this study. Fig. 1 shows a ﬂowchart of
participants in the study. Patients with history of cardiac, hep-
atic, renal diseases, and hypertension treated with ß-adrenergic
blockers, a-2-adrenergic agonists, a-methyldopa, or known
allergy to the used drugs were excluded.
In the preparation room under local anesthesia intravenous
cannula was inserted, midazolam 2 mg and ranitidine 50 mg
were given to all patients. Then patient was transferred to
the operating room, standard monitors were applied (noninva-
sive blood pressure, pulse oximetry, electrocardiogram) and
capnography after induction of anesthesia.
General anesthesia was induced with Propofol 2 mg/kg and
fentanyl 2 lg/kg, endotracheal intubation was facilitated with
atracurium 0.5 mg/kg, mechanical ventilation was adjusted to
keep the end tidal carbon dioxide between 30–35 mmHg and
anesthesia was maintained with 50% O2, 50% Air and isoﬂu-
rane 1–1.5% with topup doses of atracurium 0.15 mg/kg every
20 min. Surgical pneumatic tourniquet was applied to the thigh
during the procedure till 15 min after intra-articular injection.
Patients were randomly assigned into one of three groups (25
patients each). Randomization was done using Computer-
generated random numbers inserted into opaque concealed
envelopes; inside these envelopes was a number, which indi-
cates the group to which the patient was allocated. Group
(B) received intra-articular injection of 25 ml 0.25% bupiva-
caine only and considered as the control group, group (B/D)
received intra-articular injection of combination of 25 ml
0.25% bupivacaine and dexmedetomidine 1 mcg/kg, and
group (B/K) received intra-articular injection of combination
of 25 ml 0.25% bupivacaine and ketamine 1 mg/kg. The study
drugs were injected by the surgeon through the arthroscopy
port at the end of the procedure (Neither the surgeon and
the anesthesiologist nor the nurse looking after the patient
postoperatively was aware of the randomization sequence or
the content of the injected drugs), and if a drain was inserted
it was closed for one hour. At the end of the surgery isoﬂurane
inhalation was stopped and 100% O2 was inhaled. The neuro-
muscular block was reversed with neostigmine (0.05 mg/kg)
and atropine (0.02 mg/kg), and then tracheal extubation was
done after complete recovery of the patient with sufﬁcient
muscle power.
The use of the 10 cm Visual Analogue Scale (VAS) for pain
was explained to all patients preoperatively (0 = no pain to
10 = the worst pain). The primary outcome of the study was
the duration of postoperative analgesia guided by the pain
score. Secondary outcome variables were the total paracetamol
consumption and the requirement of meperidine rescue analge-
sia between the study groups.
VAS scores were recorded at 30 min, 1, 2, 4, 6 and 12 h
after the intra-articular injection. Scoring was conducted post-
operatively by an observer who was blinded to the study drugs.
For postoperative pain control paracetamol intravenous infu-
sion was given if the recorded VAS was 4 or more (with min-
imum 4 h time interval between successive doses of
paracetamol and rescue analgesia with meperidine 50 mg intra-
venous if the VAS score was 4 or more within this time inter-
val). The time to ﬁrst analgesic request and the total dose of
paracetamol during the ﬁrst 24 h as well as the total dose of
Excluded   n:0Aaaessed  for  eligibility n:75
Allocated to recieve  25ml  
intraarcular bupivacaine 
0.25%+ketamine 1mg/kg 
n:25
Complete the trail and 
analyzed   n:25
Allocated to recieve   25ml 
intraarcular bupivacaine 
+0.25%
dexmedetomedine1ug/kg
n:25.
Complete  the trail and 
analyzed   n:25
Allocated to receive  25ml 
intraarcular bupivacaine 
0.25%  n:25
Complete the trail and 
analyzed    n:25
Randomized n:75
Figure 1 Flowchart of participants in the study.
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any side effects as hypo- or hypertension, tachy- or bradycar-
dia, nausea, vomiting, sedation, and hallucinations was
recorded for all patients at the same time points as those
deﬁned for VAS.
3. Statistical analysis
Data were expressed using mean ± SD for quantitative vari-
ables and frequency and percentage for qualitative ones.
Comparison between groups was performed using one way
ANOVA with posthoc Tukey’s test (if parametric) or
Kruskal Wallis test followed by Mann Whitney test (if non-
parametric) for quantitative variables and Chi square or
Fisher’s exact test for qualitative ones. P value less than 0.05
was considered statistically signiﬁcant. Computer Statistical
Package of Social Science Software program, version 21
(SPSS) was used. Sample size estimation has not been done
prior to the study; instead the power was calculated after we
ﬁnished our study. At an alpha threshold of 0.001 with a groupTable 1 Demographic data – clinical variables.
Parameter B/D group (n:25)
Age (years) 36.5 ± 10.4
Weight (kg) 76 ± 7.8
Sex (male/female) 14/11
ASA (I/II) 20/5
Duration of anesthesia (min) 72.8 ± 12.7
Heart rate (min) 64.5 ± 6
Mean blood pressure (mmHg) 89.9 ± 5.6
B: bupivacaine, D: dexmedetomidine and K: ketamine. Values are mean
(P> 0.05).size of 25 patients and mean difference 0.5, the estimated study
power was 93.9%.
4. Results
There was no statistically signiﬁcant difference between the
three groups as regarding demographic data (age, sex, weight,
ASA physical status and duration of anesthesia) and postoper-
ative clinical variables (Table 1).
No serious adverse effects were recorded in the ﬁrst 24 h in
all patients. No postoperative sedation, hallucination, nausea,
vomiting, allergy or signiﬁcant heart rate and blood pressure
changes were reported.
Postoperative pain scores were signiﬁcantly less in B/D
group compared to B/K group after the ﬁrst hour and in the
next time intervals (p< 0.05). Also VAS scores were signiﬁ-
cantly lower in B/D group than in B (control) group in all mea-
surement points, and signiﬁcantly higher in B (control) group
in comparison with B/K group till the 4th hour reading, and
then it was statistically insigniﬁcant thereafter (Table 2, Fig. 2).B/K group (n:25) B group ctrl (n:25)
32.9 ± 9.7 33.6 ± 10.3
75.4 ± 7.5 74.2 ± 10.3
15/10 16/9
18/7 18/7
69.9 ± 8.1 71.0 ± 11.2
69 ± 5.2 70 ± 6.2
90.4 ± 5.2 91.5 ± 4.3
± SD and ratio. No signiﬁcant difference between the study groups,
Table 2 Visual analogue score (Mean ± SD).
B/D group B/K group B group ctrl P-value Pairwise comparisons
G1 * G2 = 0.086
VAS 30 MIN 0.5 ± 0.5 0.7 ± 0.5 1.2 ± 0.5 <0.001 G1 * G3 =<0.001
G2 * G3 = 0.001
G1 * G2 = 0.004
VAS 1H 1.3 ± 0.5 1.7 ± 0.5 2.7 ± 0.7 <0.001 G1 * G3 =<0.001
G2 * G3 =<0.001
G1 * G2 =<0.001
VAS 2H 1.7 ± 0.5 2.8 ± 0.4 3.2 ± 0.4 <0.001 G1 * G3 =<0.001
G2 * G3 = 0.002
G1 * G2 =<0.001
VAS 4H 2.3 ± 0.5 3.3 ± 0.5 3.4 ± 0.5 <0.001 G1 * G3 =<0.001
G2 * G3 = 0.243
G1 * G2 =<0.001
VAS 6H 3.9 ± 0.4 4.7 ± 0.6 4.6 ± 0.5 <0.001 G1 * G3 =<0.001
G2 * G3 = 0.739
G1 * G2 = 0.001
VAS 12H 4.3 ± 0.5 4.8 ± 0.6 5.0 ± 0.5 <0.001 G1 * G3 =<0.001
G1 * G2 = 0.198
B: bupivacaine, D: dexmedetomidine and K: ketamine. Values are mean ± SD and ratio. No signiﬁcant difference between the study groups,
(P> 0.05).
B: bupivacaine, B/D: bupivacaine/dexmedetomidine and B/K: bupivacaine/ketamine. Values are mean ± SD *: statistically signiﬁcant
(P< 0.05). G1: B/D group, G2: B/K group, G3: B group.
0.0
1.0
2.0
3.0
4.0
5.0
6.0
30 MIN 1H 2H 4H 6H 12H
DEX (B/D) B/K group B group ctrl
Figure 2 Visual analogue score (mean ± SD). B: bupivacaine B/
D: bupivacaine/dexmedetomidine and B/K: bupivacaine/ketamine
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signiﬁcantly longer in B/D group (479.2 ± 34.9 min) com-
pared to B/K group (356.7 ± 39.2 min) and control group
(312.4 ± 18.8 min). (P< 0.05) (Table 3).Table 3 Time to ﬁrst analgesic request and total dose of paracetam
Parameter B/D group (n:25) B/
Time to ﬁrst analgesic request (min) 479.2 ± 34.9 3
Total dose of paracetamol (mg) 758.0 ± 153.0 10
B: bupivacaine, B/D: bupivacaine/dexmedetomidine and B/K: bupivacain
* Statistically signiﬁcant (P< 0.05). G1: B/D group, G2: B/K group, GThe total dose of postoperative supplementary analgesia
(intravenous paracetamol infusion) in the ﬁrst 24 h was
signiﬁcantly lower in B/D group (758 ± 153 mg) in compar-
ison with B/K (1041.2 ± 178.6 mg) and control group
(1368 ± 227.2 mg) (p< 0.05) (Table 3). No need for meperi-
dine rescue analgesia was recorded in any patient.5. Discussion
The present study demonstrated that the use of intra-articular
dexmedetomidine and ketamine as adjuvant to bupivacaine for
postoperative analgesia after knee arthroscopy is safe and
effective with reduced postoperative pain and analgesic request
during the ﬁrst 24 h compared to bupivacaine alone. Also it
was noticed that intra-articular dexmedetomidine is associated
with signiﬁcant lower VAS scores and longer time to ﬁrst anal-
gesic request with reduced analgesic consumption in compar-
ison with intra-articular ketamine.
Dexmedetomidine is an alpha-2 agonist which produces its
effect through spinal, supraspinal and peripheral actions [9].ol.
K group (n:25) B group (n:25) Pairwise comparisons
56.7 ± 39.2 312.4 ± 18.8 G1 * G2 =<0.001*
G1 * G3 =<0.001*
G2 * G3 =<0.001*
41.2 ± 178.6 1368.0 ± 227.2 G1 * G2 =<0.001*
G1 * G3 =<0.001*
G2 * G3 =<0.001*
e/ketamine. Values are mean ± SD.
3: B group.
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appears to be mainly due to direct local action. However, a
central analgesic effect resulting from systemic absorption
cannot be excluded. The mechanism of analgesic effect of
intra-articular dexmedetomidine might be similar to that of
intra-articular clonidine.
Clonidine produces analgesia mainly through inhibition of
the transmission of nociceptive stimulation in the dorsal horn
of spinal cord [10]. Clonidine is reported to mimic the effect of
noradrenaline release by descending inhibitory control path-
ways [11]. Topical administration of clonidine may reduce pain
intensity in patients with sympathetically maintained pain,
suggesting a peripheral site of action [12]. Dexmedetomidine,
like clonidine, may provide local anesthetic effects that inhibit
the conduction of nerve signals through C and Ad ﬁbers and
may stimulate the release of enkephalin-like substances at
peripheral sites [13,14].
The results of our study are in agreement with the study of
El-Hamamsy et al., who showed that intra-articular
dexmedetomidine 1 mcg/kg as adjuvant to bupivacaine signif-
icantly enhanced the postoperative analgesia after arthroscopic
knee surgery, with an increased time to ﬁrst analgesic request
(450 ± 85 min) in comparison with bupivacaine alone
(230 ± 85 min), and decreased total postoperative meperidine
requirement during the ﬁrst 24 h [15].
A study was done to investigate the effect of intra-articular
magnesium versus dexmedetomidine for postoperative analge-
sia after knee arthroscopic meniscectomy concluded that both
intra-articular magnesium sulfate and dexmedetomidine
enhance postoperative analgesia after knee arthroscopic
meniscectomy with signiﬁcantly longer time to postoperative
analgesic request 461.5 ± 39.2 min and 354 ± 34 min respec-
tively without adverse systemic side effects of these drugs [16].
Paul et al. demonstrated that, administration of
dexmedetomidine as adjuvant to local anesthetic ropivacaine
improves the quality and duration of postoperative analgesia
and reduces the consumption of fentanyl citrate, with delay
time 10.84 ± 2.6 h between intra-articular injection of ropiva-
caine with dexmedetomidine and supplementary analgesic
administration by PCA pump [17].
In the present study the analgesic effect of intra-articular
ketamine in combination with bupivacaine was superior to
bupivacaine alone with signiﬁcantly lower VAS at 30 min,
1 h and 2 h. Also the time to ﬁrst analgesic request was signif-
icantly longer with decreased mean consumption of paraceta-
mol analgesia in the ﬁrst 24 h.
Ketamine is proved to have local effects; it interacts with
multitude of receptors including opioid, cholinergic, adrener-
gic, serotonergic and NMDAr, all of which have signiﬁcant
role in analgesia [18].
Dal et al used ketamine intra-articularly and reported a sig-
niﬁcant analgesic effect that was comparable to intra-articular
neostigmine, without reported side effects [19].
The study investigating the analgesic effect of intra-
articular ketamine and tramadol revealed that both ketamine
and tramadol produce peripheral analgesic effect when
injected intra-articularly in the knee following arthroscopic
surgeries. Both agents reduced pain scores and opioid con-
sumption and had no systemic side effects [20].
Lashgarinia et al. demonstrated that, the addition of keta-
mine 2 mg/kg to 5 mg/kg lidocaine 1.5% in ultrasound-guided
brachial plexus block decreases the postoperative pain and thetime to ﬁrst analgesic request in the ketamine group was signif-
icantly longer than in the control group (8.93 ± 1.0 vs.
7.30 ± 1.9), respectively. Therefore, it could be considered as
an option in the brachial plexus block to enhance the analgesic
action of lidocaine [21].
Ayoglu et al. concluded that administration of intra-
articular tramadol-ketamine combination was found to be
more effective in decreasing postoperative analgesic consump-
tion in comparison with intra-articular tramadol alone with
lower postoperative pain scores [22].
The results of the study done by Batra et al. showed that
intra-articular injection of a combination of 1 mg/kg ketamine
and 0.25% bupivacaine to a total volume of 20 mL following
surgery provides better pain relief with longer duration of
analgesia 5.1 ± 1.1 h compared to ketamine 1 mg/kg alone
which was 1.7 ± 0.9 h. However, 24 h consumption of anal-
gesic was similar [23].
A limitation of our study is that, there was no follow-up to
detect any local tissue damage in the intra-articular space fol-
lowing injection of the study drugs which require long time.
Further studies are also needed to deﬁne the optimal analgesic
dose without hemodynamic changes of intra-articular
dexmedetomidine and ketamine in combination with bupiva-
caine for control of pain after knee arthroscopy.6. Conclusion
Both dexmedetomidine and ketamine are safe and effective
when added to intra-articular bupivacaine but dexmedeto-
midine/bupivacaine has better analgesic proﬁle with lower per-
ception of pain, as assessed by the VAS score, longer time to
analgesic request and reduced total dose of analgesia during
ﬁrst 24 h after knee arthroscopy in comparison with
ketamine/bupivacaine or bupivacaine alone.
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